SIAP
SCNI

Sterling Investment Advisors (Pennsylvania)’s Scinai Immunotherapeutics SCNI Stock Holding History

Sterling Investment Advisors (Pennsylvania)’s Portfolio SCNI Stock Details SCNI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Hold
0
– – – 430
2022
Q2 		– Hold
0
– – – 616
2022
Q1 		– Hold
0
– – – 621
2021
Q4 		– Hold
0
– – – 617
2021
Q3 		– Hold
0
– – – 599
2021
Q2 		– Hold
0
– – – 563
2021
Q1 		– Hold
0
– – – 536
2020
Q4 		– Hold
0
– – – 475
2020
Q3 		– Hold
0
– – – 421
2020
Q2 		– Hold
0
– – – 439
2020
Q1 		– Hold
0
– – – 432

Other funds holding SCNI

Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
TPWA
TRUE Private Wealth Advisors Salem, Oregon $1.16B AUM 36.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
APC
Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return